Search Results

Keywords: cnd

Postponed vote on WHO cannabis recommendations reveals international disagreements, uphill battle ahead

The 63rd session of the United Nations Commission on Narcotic Drugs (CND) in Vienna this week laid bare deep divisions in the international community over the World Health Organization (WHO) cannabis scheduling recommendations. Rather than voting on recommendations that would have far-reaching implications for the global cannabis industry, the CND postponed the vote to December. The […]

Read More

Expected delay in vote on WHO cannabis scheduling recommendations spurs US official to express ‘regret’ over decision

A United Nations drug policy agency this week is expected to postpone a vote on the World Health Organization’s cannabis scheduling recommendations, prompting a U.S. representative in Vienna to voice “regret” over the delay. Several other countries, however, welcomed the expected postponement of the vote until December. The expected delay by the United Nations Commission […]

Read More

In major shift, UN drug chief questions whether control treaties involving cannabis are out of date

The president of the narcotics enforcement agency of the United Nations is questioning whether the agency’s decades-old drug conventions are outdated given global policy developments in recent years involving drugs such as cannabis. During a presentation Thursday for the International Narcotics Control Board’s (INCB) 2019 annual report, President Cornelis P. de Joncheere discussed the developments taking place with regard […]

Read More

European Commission falls short on WHO cannabis recommendations, experts say

The European Commission’s proposal that European Union-member countries support three of the six World Health Organization (WHO) cannabis scheduling recommendations does not merit much celebration from the cannabis industry, according to international drug policy experts. “The only good point in the draft’s common position is that the EU should support the deletion of cannabis from Schedule IV, but […]

Read More

European Commission proposes unified EU vote on WHO cannabis scheduling recommendations

In advance of the March session of the United Nations Commission on Narcotic Drugs (CND), the European Union’s executive branch has proposed that EU member nations vote in favor of three of the six World Health Organization (WHO) cannabis scheduling recommendations. The European Commission “Proposal for a Council Decision” is meaningful because – if adopted by […]

Read More

Top 10 global cannabis stories of 2019: WHO backs rescheduling, Linton out at Canopy, Canadian firms eye US & more

Cannabis markets in Canada and elsewhere in the world went on a roller-coaster ride in 2019, as irrational expectations gave way to more realistic market assessments. Global medical marijuana markets, corporations and top executives experienced breakthroughs and setbacks this past year. That’s the gist of the 10 most widely read business stories carried by Marijuana Business Daily […]

Read More

FDA deadline to comment on international rescheduling of cannabis nears

The U.S. Food and Drug Administration (FDA) reopened a comment period for public input in preparation for the international discussion to reschedule marijuana  as recommended by the World Health Organization (WHO). The deadline to submit comments is Sept. 30. The nonbinding rescheduling recommendations made by the WHO’s Expert Committee on Drug Dependence could have a significant impact […]

Read More

UN Commission on Narcotic Drugs delays vote on WHO cannabis recommendations

The United Nations Commission on Narcotic Drugs (CND) will not vote on the World Health Organization’s cannabis recommendations at its March session in Vienna. That news comes after the release of the recommendations, which had been expected in December, was delayed. The proposal, made by the World Health Organization’s Expert Committee on Drug Dependence, could have […]

Read More

Though a ‘positive step,’ WHO recommendations on cannabis fall short for some

The World Health Organization (WHO) made great strides in its recommendations on how cannabis should be scheduled, but the global industry believes there’s more work to be done. Martin Jelsma, drugs and democracy program director, at the Netherlands-based Transnational Institute, emphasized to Marijuana Business Daily that there are “very positive elements in the WHO recommendations,” including: Recognition […]

Read More

WHO postpones recommendation for rescheduling cannabis at UN summit

The World Health Organization (WHO) postponed its much-anticipated recommendations about the international scheduling of cannabis, citing a need for more time to review its findings. The recommendations were expected to be released Dec. 7 at the Commission on Narcotic Drugs (CND) 61st reconvened session in Vienna. Recommendations about several other substances were included in the WHO presentation, but […]

Read More

Key UN summit could lead to international rescheduling of cannabis

A crucial milestone for the global industry could be achieved this week, as the World Health Organization (WHO) presents its findings on cannabis to the Commission on Narcotic Drugs (CND) in Vienna. The CND reconvened its 61st session on Dec. 5. The WHO’s Expert Committee on Drug Dependence (ECDD) held meetings in June and November dedicated to pre-review and review […]

Read More